Zobrazeno 1 - 10
of 1 254
pro vyhledávání: '"Intestinal epithelial barrier"'
Publikováno v:
European Pharmaceutical Journal, Vol 71, Iss 1, Pp 43-52 (2024)
While many types of diabetes medications are currently available, orally administered formulations of glucagon-like peptide-1 (GLP-1) receptor agonists have recently been launched. Therefore, gastrointestinal epithelial cells will be increasingly exp
Externí odkaz:
https://doaj.org/article/488d8589ad5b4523b9487db4bd9b345d
Autor:
Meng Liu, Yuhui Wang, Xiaotian Xu, Guoqiang Guan, Shu Zhang, Shengnan Zhu, Yang Liu, Yizhun Zhu, Xiaoqun Duan
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundIntestinal epithelial barrier dysfunction is intricately linked to the pathogenesis of ulcerative colitis (UC). Dietary interventions that bolster intestinal epithelial barrier function can effectively thwart UC onset. Our prior research re
Externí odkaz:
https://doaj.org/article/2911903d1c0746c98b8fbd4926f82617
Autor:
Hyun-Woo Cho, Kangmin Seo, Min Young Lee, Sang-Yeob Lee, Kyoung Min So, Ki Hyun Kim, Ju Lan Chun
Publikováno v:
Journal of Animal Reproduction and Biotechnology, Vol 39, Iss 2, Pp 105-113 (2024)
Background: Aflatoxin B1 (AFB1) is a toxic metabolite generated by Aspergillus species and is commonly detected during the processing and storage of food; it is considered a group I carcinogen. The hepatotoxic effects, diseases, and mechanisms induce
Externí odkaz:
https://doaj.org/article/911def06d12a4ec2bfca6b32801e8a65
Autor:
Wei Ke, Jinjun Wu, Hongbin Li, Siyu Huang, Huibiao Li, Yongfu Wang, Yingxiu Wu, Jie Yuan, Shuncong Zhang, Hongmei Tang, Kaijun Lei
Publikováno v:
Heliyon, Vol 10, Iss 12, Pp e33102- (2024)
Changji'an Formula (CJAF) is a Chinese herbal compound, which is effective against irritable bowel syndrome with predominant diarrhea (IBS-D) in clinic. However, the molecular mechanism has not been well defined. In the current study, the potential t
Externí odkaz:
https://doaj.org/article/33ae3df124e049548e2ae30178f59c13
Autor:
Hailun Li, Xing Pu, Yongtao Lin, Xinxin Yu, Jing Li, Lin Bo, Hongwu Wang, Yong Xu, Xiang Li, Donghui Zheng
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Ethnopharmacological relevance:As a representative classical prescription, Sijunzi decoction has powerful therapeutic effects on spleen–stomach qi insufficiency. Ulcerative colitis (UC) is a chronic, diffuse, and non-specifically inflammatory disor
Externí odkaz:
https://doaj.org/article/6310c7efc89942648efeb19ae291a4fe
Autor:
Yu Lei, Yiting Yan, Junyu Zhong, Yitong Zhao, Yangbin Xu, Ting Zhang, Hui Xiong, Yulin Chen, Xiaolong Wang, Ke Zhang
Publikováno v:
Heliyon, Vol 10, Iss 7, Pp e28486- (2024)
Enterococcus durans, is a potential functional strain with the capacity to regulate intestinal health and ameliorate colonic inflammation. However, the strain requires further investigation regarding its safety profile and potential mechanisms of col
Externí odkaz:
https://doaj.org/article/8e93c23e485047b898bdbcb28212fc66
Autor:
Juan Wei, Chunyan Chen, Jing Feng, Shuping Zhou, Xiaoyue Feng, Zhao Yang, Heng Lu, Hui Tao, Liuying Li, Huabing Xv, Ji Xuan, Fangyu Wang
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-15 (2023)
Abstract Background Ulcerative colitis (UC) is a chronic inflammatory disease of the intestine characterized by a compromised intestinal epithelial barrier. Mucin glycans are crucial in preserving barrier function during bacterial infections, althoug
Externí odkaz:
https://doaj.org/article/ace55356fde0448fa08f3c99e5e3b073
Autor:
Huichao Xie, Xiong Zeng, Wensheng Wang, Wei Wang, Ben Han, QianShan Tan, Qiu Hu, Xingyu Liu, Shuaishuai Chen, Jun Chen, Lihua Sun, Yihui Chen, Weidong Xiao
Publikováno v:
Molecular Biomedicine, Vol 4, Iss 1, Pp 1-14 (2023)
Abstract Damage to the intestinal epithelial barrier (IEB) has been reported under high-altitude (HA) conditions and may be responsible for HA-associated gastrointestinal (GI) disorders. However, this pathogenetic mechanism does not fully explain the
Externí odkaz:
https://doaj.org/article/2c1c562f5ebc4bb49e2c8c754ecd5dd1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Longyuan Zhou, Liguo Zhu, Xiaomin Wu, Shixian Hu, Shenghong Zhang, Min Ning, Jun Yu, Minhu Chen
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-19 (2023)
Abstract Background Disrupted intestinal epithelial barrier is one of the major causes of Crohn’s disease (CD). Novel molecular targets for intestinal epithelial barrier are essential to treatment of CD. Transmembrane and immunoglobulin domain-cont
Externí odkaz:
https://doaj.org/article/71433540802c4d8a9e02be4b9c2cdad8